Human fibrinogen (Guangdong Danxia Biopharm)

人纤维蛋白原(广东丹霞)

Report date: 2024/07/03 09:16:58

Base Information

Drug NameHuman fibrinogen (Guangdong Danxia Biopharm)
Drug Alias NameN/A
ClassificationBiologics > Blood componentsBiologics > Biosimilar
Mechanisms of ActionFibrinogen replacements
TargetsFibrinogen
Therapy Area/IndicationsAfibrinogenemia
Global Approved IndicationsAfibrinogenemia
Approved Indications in ChinaAfibrinogenemia
Original Approved Country/TerritoryMainland China
Original Approved Date2001/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsAfibrinogenemia
Inactive IndicationsN/A

Other Information

ATC CodeB02BB01